Envoy Medical, Inc. (COCH) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.06M | -5.68M | -4.33M | -4.46M | -3.73M | -4.39M | -2.81M | -4.65M | -5.85M | -11.14M | 1.1M | -4.03M |
| Operating CF Margin % | -15541.03% | -7580% | -10311.9% | -5717.95% | -8097.83% | -10447.62% | -5012.5% | -6832.35% | -9908.47% | -11731.58% | 1373.75% | -6403.17% |
| Operating CF Growth % | -62.71% | -29.56% | -54.29% | 4% | 36.28% | 60.63% | -355.41% | -15.17% | -94.15% | -368.47% | 120.92% | -104.67% |
| Net Income | -4.35M | -6.59M | -6.48M | -5.69M | -5M | -6.28M | -5.96M | -3.95M | -6.27M | -4.89M | 1.47M | -13.25M |
| Depreciation & Amortization | 73K | 80K | 76K | 85K | 61K | 48K | 49K | 42K | 34K | 48K | 29K | 29K |
| Stock-Based Compensation | 44K | -64K | 324K | 146K | 160K | 0 | 0 | 142K | 123K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.07M | 807K | 989K | 922K | 130K | 2.85M | 1.95M | -1.11M | 1.46M | 515K | -5.12M | 8.79M |
| Working Capital Changes | -758K | 78K | 762K | 77K | 922K | -1.01M | 1.16M | 228K | -1.19M | -6.81M | 4.71M | 390K |
| Change in Receivables | 5K | 1K | 9K | 2K | 753K | -589K | -27K | 19K | 25K | -137K | -54K | -20K |
| Change in Inventory | 44K | 125K | -110K | 37K | 74K | -143K | 203K | -300K | -140K | -30K | 14K | 6K |
| Change in Payables | -1.22M | 412K | 1.01M | -43K | 10K | -222K | 168K | 676K | -641K | -1.83M | 1.02M | 339K |
| Cash from Investing | 0 | -172K | 0 | -1K | -6K | 534K | -615K | -790K | -109K | -21K | -62K | -11K |
| Capital Expenditures | 0 | -172K | 0 | -1K | -6K | 534K | -615K | -790K | -109K | -21K | -62K | -11K |
| CapEx % of Revenue | - | 229.33% | - | 1.28% | 13.04% | 1271.43% | 1098.21% | 1161.76% | 184.75% | 22.11% | 77.5% | 17.46% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 389.3M | 0 |
| Cash from Financing | 27.57M | 6.04M | 2.6M | 4.44M | 3.55M | 4.91M | 6.1M | 2.24M | 6.68M | -1.45M | 15.74M | 3M |
| Debt Issued (Net) | -208K | -191K | -267K | 4.76M | 4.77M | 4.08M | 7.5M | 2.24M | 5M | -563K | 3M | 3M |
| Equity Issued (Net) | 27.78M | 6.29M | 2.87M | 281K | 0 | 1.44M | 434K | 0 | 1.68M | -891K | 400.34M | 0 |
| Dividends Paid | -1.35M | 1K | 0 | -607K | -1.21M | -614K | -1.83M | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 387.61M | 0 |
| Other Financing | 1.35M | -62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -387.61M | 0 |
| Net Change in Cash | 21.51M | 183K | -1.73M | -25K | -171K | 1.06M | 2.68M | -3.2M | 727K | -12.62M | 16.77M | -1.05M |
| Free Cash Flow | -6.06M | -5.86M | -4.33M | -4.46M | -3.73M | -3.85M | -3.42M | -5.44M | -5.96M | -11.17M | 1.04M | -4.04M |
| FCF Margin % | -15541.03% | -7809.33% | -10311.9% | -5719.23% | -8110.87% | -9176.19% | -6110.71% | -7994.12% | -10093.22% | -11753.68% | 1296.25% | -6420.63% |
| FCF Growth % | -62.45% | -51.97% | -26.56% | 17.94% | 37.35% | 65.48% | -429.99% | -34.39% | -93.97% | -361.41% | 119.1% | -97.8% |
| FCF per Share | -0.09 | -0.30 | -0.22 | -0.23 | -0.17 | -0.18 | -0.17 | -0.28 | -0.32 | -0.57 | 0.05 | -0.21 |
| FCF Conversion (FCF/Net Income) | 1.39x | 0.86x | 0.67x | 0.78x | 0.75x | 0.95x | 0.47x | 1.18x | 0.93x | 2.28x | 0.70x | 0.30x |
| Interest Paid | 0 | 0 | 0 | 7K | 13K | 0 | 0 | 9K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |